Literature DB >> 2112830

Metastases from malignant melanoma to the axial skeleton: a CT study of frequency and appearance.

R M Patten1, W P Shuman, S Teefey.   

Abstract

Radiologic detection of bone lesions from malignant melanoma is reported to be uncommon or infrequent. To ascertain the characteristics and frequency of detection of melanoma metastases to the axial skeleton by CT, we retrospectively reviewed 464 body CT studies of 125 consecutive melanoma patients for presence, appearance, and site of skeletal metastases. Results were correlated with patient's age, sex, clinical course, and both the Clark and Breslow classifications of the primary lesion. Of 98 patients with metastatic disease evident on their CT studies, 17 (17%) had bony metastases; two (12%) of these 17 patients had skeletal lesions as the only CT evidence of metastatic disease. Metastatic bony lesions were predominantly osteolytic, slightly expansile, and commonly located in the spine. Associated soft-tissue masses were frequent, but periosteal reaction and identifiable tumor matrix were not seen. Skeletal metastases were found only in those patients with thick or intermediate primary melanoma (Breslow) classified as Clark level III or greater, and the CT demonstration of osseous metastases was a poor prognostic sign. The data suggest that CT detection of skeletal melanoma metastases is not uncommon. When CT is performed to evaluate for metastatic melanoma, the axial skeleton should be carefully examined, especially in those patients with more advanced primary lesions.

Entities:  

Mesh:

Year:  1990        PMID: 2112830     DOI: 10.2214/ajr.155.1.2112830

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

Review 1.  Bone metastasis: mechanisms and therapeutic opportunities.

Authors:  Larry J Suva; Charity Washam; Richard W Nicholas; Robert J Griffin
Journal:  Nat Rev Endocrinol       Date:  2011-01-04       Impact factor: 43.330

Review 2.  HIF targets in bone remodeling and metastatic disease.

Authors:  Rachelle W Johnson; Ernestina Schipani; Amato J Giaccia
Journal:  Pharmacol Ther       Date:  2015-02-12       Impact factor: 12.310

3.  Metastatic Melanoma in the Femur - Case Report with Review of Literature: a Pathologist's Point of View.

Authors:  Mariana Costache; Alexandra Stoica; Andreea Contolenco; Diana Costache; Catalin Cirstoiu; Olga Simionescu; Simion George
Journal:  Maedica (Buchar)       Date:  2014-03

Review 4.  The best of both worlds - managing the cancer, saving the bone.

Authors:  Issam Makhoul; Corey O Montgomery; Dana Gaddy; Larry J Suva
Journal:  Nat Rev Endocrinol       Date:  2015-10-27       Impact factor: 43.330

5.  Low back pain as the presenting sign in a patient with primary extradural melanoma of the thoracic spine--a metastatic disease 17 years after complete surgical resection.

Authors:  Darko Katalinic; Branimir Anic; Ranka Stern-Padovan; Miroslav Mayer; Mirna Sentic; Nada Cikes; Kamelija Zarkovic; Snjezana Dotlic; Stjepko Plestina
Journal:  World J Surg Oncol       Date:  2011-11-17       Impact factor: 2.754

6.  Malignant Course of a Metastatic Melanoma During Pregnancy: A Case Report.

Authors:  Cugati Goutham; Jain Pradeep Kumar; Pande Anil; Symss Nigel Peter; Ramamurthi Ravi; Vasudevan Mathabushi Chakravorthy
Journal:  World J Oncol       Date:  2011-04-09

Review 7.  Staging of cutaneous melanoma.

Authors:  P Mohr; A M M Eggermont; A Hauschild; A Buzaid
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

8.  Complications of bone metastases from malignant melanoma.

Authors:  Jamal Zekri; Maria Marples; Dominic Taylor; Kiran Kandukurti; Lucy McParland; Janet E Brown
Journal:  J Bone Oncol       Date:  2017-08-18       Impact factor: 4.072

9.  A Potential Role of RUNX2- RUNT Domain in Modulating the Expression of Genes Involved in Bone Metastases: An In Vitro Study with Melanoma Cells.

Authors:  Michela Deiana; Luca Dalle Carbonare; Michela Serena; Samuele Cheri; Simona Mutascio; Alberto Gandini; Giulio Innamorati; Pamela Lorenzi; Michela Cumerlato; Jessica Bertacco; Franco Antoniazzi; Maria Grazia Romanelli; Monica Mottes; Donato Zipeto; Maria Teresa Valenti
Journal:  Cells       Date:  2020-03-19       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.